Confirmatory Testing for Positive HSV-1 and HSV-2 Antibody Screen
For a patient with a positive HSV-1 and HSV-2 antibody screen, order Western blot (immunoblot) as the confirmatory test, particularly if the initial test showed a low positive index value (<3.0 on HerpeSelect assay). 1
Understanding the Problem with Initial Screening Tests
The commercially available FDA-approved HSV serologic tests (enzyme immunoassays and chemiluminescent immunoassays) have significant limitations that necessitate confirmatory testing:
- HSV-2 specificity is poor: Only 57.4% overall specificity compared to Western blot, with index values of 1.1-2.9 having merely 39.8% specificity 1
- HSV-1 sensitivity is inadequate: Only 70.2% sensitivity, leading to false-negative results 1
- Cross-reactivity occurs: Patients with HSV-1 infection are more likely to have false-positive HSV-2 results with low index values 1
Confirmatory Testing Algorithm
If HerpeSelect or Similar EIA Was Used:
Check the index value on the initial test report
- Index value ≥3.0: May be sufficient for diagnosis without further testing, though false positives still occur even above 3.5 1
- Index value <3.0: Confirmatory testing is essential
Order confirmatory test based on availability:
Critical Timing Consideration:
- Window period: HSV-2 antibodies may not appear for up to 12 weeks after exposure 1
- If testing was performed soon after potential exposure and results are negative, repeat testing at 12 weeks before definitively ruling out infection 1
When Confirmatory Testing Is Most Critical
Confirmatory testing is particularly important because:
- HSV-2 is a chronic, lifelong infection with significant psychological and sexual health implications 1
- False-positive diagnosis can cause unnecessary distress and affect relationships
- In low-prevalence populations, positive predictive value of screening tests alone is inadequate 1
Important Caveats
Do not rely on serology alone if active lesions are present. Western blotting detects previous exposure but is less useful for diagnosing active infections 2. For symptomatic patients with lesions:
- PCR from lesion swab is the preferred diagnostic method 2, 3
- Serology serves as adjunct only if PCR/culture is negative but clinical suspicion remains high 1
What NOT to Order
- Non-type-specific HSV antibody tests: These cannot distinguish HSV-1 from HSV-2 and should never be used 4, 5
- POCkit HSV-2 point-of-care test alone: Has poor specificity, making positive results likely false positives in low-prevalence populations 6
- Repeat EIA/CLIA using the same assay: This does not improve accuracy
The bottom line: Western blot remains the gold standard confirmatory test for HSV serology, and providers must be aware that commercially available screening tests have substantial limitations that can lead to misdiagnosis if used without confirmation 1.